Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Shedding of soluble epidermal growth factor receptor (sEGFR) is mediated by a metalloprotease/fibronectin/integrin axis and inhibited by cetuximab.

Wilken JA, Perez-Torres M, Nieves-Alicea R, Cora EM, Christensen TA, Baron AT, Maihle NJ.

Biochemistry. 2013 Jul 2;52(26):4531-40. doi: 10.1021/bi400437d. Epub 2013 Jun 21.

PMID:
23731208
2.

Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer.

Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ.

Clin Cancer Res. 2010 Mar 15;16(6):1904-14. doi: 10.1158/1078-0432.CCR-09-2282. Epub 2010 Mar 9.

3.

Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer.

Baron AT, Lafky JM, Boardman CH, Cora EM, Buenafe MC, Liu D, Rademaker A, Fishman DA, Podratz KC, Reiter JL, Maihle NJ.

Cancer Treat Res. 2009;149:189-202. doi: 10.1007/978-0-387-98094-2_9. Review. No abstract available.

PMID:
19763437
4.

Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.

Perez-Torres M, Valle BL, Maihle NJ, Negron-Vega L, Nieves-Alicea R, Cora EM.

Exp Cell Res. 2008 Oct 1;314(16):2907-18. doi: 10.1016/j.yexcr.2008.07.013. Epub 2008 Jul 25.

PMID:
18687326
5.

Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole.

Lafky JM, Baron AT, Cora EM, Hillman DW, Suman VJ, Perez EA, Ingle JN, Maihle NJ.

Cancer Res. 2005 Apr 15;65(8):3059-62.

6.

Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.

Baron AT, Cora EM, Lafky JM, Boardman CH, Buenafe MC, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):103-13.

7.

EGF/ErbB receptor family in ovarian cancer.

Maihle NJ, Baron AT, Barrette BA, Boardman CH, Christensen TA, Cora EM, Faupel-Badger JM, Greenwood T, Juneja SC, Lafky JM, Lee H, Reiter JL, Podratz KC.

Cancer Treat Res. 2002;107:247-58. Review.

PMID:
11775453
8.

Induction of experimental myasthenia gravis in rhesus monkeys: a model for the study of the human disease.

Toro-Goyco E, Cora EM, Kessler MJ, Martinez-Carrion M.

P R Health Sci J. 1986 Apr;5(1):13-8.

PMID:
3797623
9.

Role of high-fat diet in tumorigenesis in C57BL/1 mice.

El-Khatib SM, Cora EM.

J Natl Cancer Inst. 1981 Feb;66(2):297-301.

PMID:
6935479

Supplemental Content

Support Center